Growth Metrics

Emergent BioSolutions (EBS) Other Non-Current Assets (2016 - 2026)

Emergent BioSolutions has reported Other Non-Current Assets over the past 16 years, most recently at $13.0 million for Q1 2026.

  • For Q1 2026, Other Non-Current Assets rose 251.35% year-over-year to $13.0 million; the TTM value through Mar 2026 reached $13.0 million, up 251.35%, while the annual FY2025 figure was $14.2 million, 24.87% down from the prior year.
  • Other Non-Current Assets for Q1 2026 was $13.0 million at Emergent BioSolutions, down from $14.2 million in the prior quarter.
  • Over five years, Other Non-Current Assets peaked at $57.1 million in Q1 2022 and troughed at $500000.0 in Q1 2024.
  • A 4-year average of $17.9 million and a median of $9.8 million in 2024 define the central range for Other Non-Current Assets.
  • Biggest five-year swings in Other Non-Current Assets: crashed 60.08% in 2022 and later soared 640.0% in 2025.
  • Year by year, Other Non-Current Assets stood at $40.8 million in 2022, then tumbled by 53.68% to $18.9 million in 2024, then decreased by 24.87% to $14.2 million in 2025, then dropped by 8.45% to $13.0 million in 2026.
  • Business Quant data shows Other Non-Current Assets for EBS at $13.0 million in Q1 2026, $14.2 million in Q4 2025, and $3.7 million in Q3 2025.